Trial Library

Name: Trial Library
Brand: Trial Library

AI Native

Trial Library is a B2B health-technology platform that uses AI and evidence-based workflows to identify and pre-screen oncology patients, optimize internal referral routing, and provide pre-consent navigation to accelerate clinical trial enrollment.

Est 2022|Valuation $55M|Raised $17M

LinkedIn 2K|Web traffic 23K|FTEs 35

01Competitive Landscape

Comparative narrative

Areas where Trial Library’s model may be advantageous: - Service plus software blend: the described navigator layer is intended to address practical barriers (transport, lodging, coordination) that software-only matching products may not cover - Provider-centered workflows: public materials emphasize routing referrals to sites and maintaining provider communication, which could improve internal referral performance if adopted Areas where alternatives may be more appropriate: - Deep 6 AI: for organizations whose primary need is rapid cohort discovery from EHR data, cohort-discovery-first vendors may be a closer match - Massive Bio and other patient-matching providers: for sponsor programs focused on large-scale patient acquisition, specialized recruitment vendors may offer more mature sponsor-facing operations and datasets - Patient platforms (e.g., Outcomes4Me): for organizations that want broader patient engagement features beyond trial matching (symptom tracking, educational resources), patient platform vendors may be more comprehensive Market adoption / trend notes: - The vendor’s public materials report operations across a sizable network of clinics and providers. Buyers should validate active usage and outcomes, not only contractual coverage.

	Trial Library	Massive Bio	Deep 6 AI
Starting Price	Not public (demo-based)	Patient services often marketed as no cost to patients; enterprise/sponsor pricing varies	Not public (enterprise sales typical)
Primary Audience	Community oncology networks, sites, and sponsors needing provider activation plus navigation services	Sponsors and patients seeking matching and recruitment support; strong patient-facing component	Health systems/sites needing cohort discovery and rapid feasibility/recruitment from clinical data
Key Strength	Combines provider trial search/referrals with navigation services; vendor-reported network scale	Patient-facing matching with sponsor partnerships and available case study materials	Cohort discovery and clinical-data-first approach for feasibility and recruitment
Key Weakness	Limited independent customer reviews publicly; pricing opaque	Depending on engagement model, enterprise economics can be substantial	Integration complexity and enterprise sales cycle; pricing not transparent

01Competitive Landscape

Comparative narrative

Areas where Trial Library’s model may be advantageous:

Service plus software blend: the described navigator layer is intended to address practical barriers (transport, lodging, coordination) that software-only matching products may not cover
Provider-centered workflows: public materials emphasize routing referrals to sites and maintaining provider communication, which could improve internal referral performance if adopted

Areas where alternatives may be more appropriate:

Deep 6 AI: for organizations whose primary need is rapid cohort discovery from EHR data, cohort-discovery-first vendors may be a closer match
Massive Bio and other patient-matching providers: for sponsor programs focused on large-scale patient acquisition, specialized recruitment vendors may offer more mature sponsor-facing operations and datasets
Patient platforms (e.g., Outcomes4Me): for organizations that want broader patient engagement features beyond trial matching (symptom tracking, educational resources), patient platform vendors may be more comprehensive

Market adoption / trend notes:

The vendor’s public materials report operations across a sizable network of clinics and providers. Buyers should validate active usage and outcomes, not only contractual coverage.

	Trial Library	Massive Bio	Deep 6 AI
Starting Price	Not public (demo-based)	Patient services often marketed as no cost to patients; enterprise/sponsor pricing varies	Not public (enterprise sales typical)
Primary Audience	Community oncology networks, sites, and sponsors needing provider activation plus navigation services	Sponsors and patients seeking matching and recruitment support; strong patient-facing component	Health systems/sites needing cohort discovery and rapid feasibility/recruitment from clinical data
Key Strength	Combines provider trial search/referrals with navigation services; vendor-reported network scale	Patient-facing matching with sponsor partnerships and available case study materials	Cohort discovery and clinical-data-first approach for feasibility and recruitment
Key Weakness	Limited independent customer reviews publicly; pricing opaque	Depending on engagement model, enterprise economics can be substantial	Integration complexity and enterprise sales cycle; pricing not transparent

Trial Library

01Competitive Landscape

Comparative narrative

02Market Map

01Competitive Landscape

Comparative narrative

02Market Map